Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/10748
Title: Association of PC and AT levels in the early phase of STEMI treated with pPCI with LV systolic function and 6-month MACE
Authors: Obradović D.
Begic, Edin
Jankovic, Slobodan
Romanovic R.
Djenić N.
Dzudovic B.
Jovic Z.
Malovic D.
Subota V.
Stavric M.
Ljuca, Farid
Kušljugic Z.
Issue Date: 2020
Abstract: © 2020, © Belgian Society of Internal Medicine and Royal Belgian Society of Laboratory Medicine (2020). Objectives: To examine a relationship between protein C (PC) and antithrombin III (AT III) activities with ejection fraction of left ventricle (EFLV), in the early phase of acute ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI), and to investigate whether PC and AT III are associated with major adverse cardiovascular events (MACE) within 6 months following from pPCI. Patients and methods: The research had a prospective character and included 357 patients who had, following the diagnosis of the STEMI, undergone pPCI at the Clinic of Cardiology and Emergency Internal Medicine, Military Medical Academy, Belgrade, Serbia, from January 2010 until April 2019. Results: The EFLV positively correlated with PC values (rho = 0.229). There was a statistically significant increase in the PC values between patients with MACE compared with those without MACE at 6 months’ follow-up evaluation (p < 0.0001). Also, significant difference in PC values between patients who died in hospital and those who were alive at 6 months’ follow-up (p < 0.01) was observed. PC values were different across different EFLV groups (p < 0.001), increasing from the 1st to the 4th EFLV quartiles: the median and the interquartile values for the 1st, 2nd, 3rd and 4th quartiles were 1.0400IU/l ± 0.15, 1.1400IU/l ± 0.15, 1.1350IU/l ± 0.16 and 1.2200IU/l ± 0.14, respectively. Conclusion: Increased PC activity in the early phase of STEMI is associated with higher EFLV 5 days after the pPCI as well as with MACE at 6 months after the pPCI.
URI: https://scidar.kg.ac.rs/handle/123456789/10748
Type: article
DOI: 10.1080/17843286.2020.1766850
ISSN: 1784-3286
SCOPUS: 2-s2.0-85085702775
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

108

Downloads(s)

4

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access
29.86 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.